VGBio (DBA PhysIQ)

Naperville, Illinois, United States  All United States companies → — Founded 2005
Clinical AI Platform Wearables / RPM
Cardiology Hospital Medicine Internal Medicine
Drug Discovery & Research Wearables & Remote Monitoring (RPM)
Series B
Claim this company

About VGBio (DBA PhysIQ)

PhysIQ (VGBio) is a healthcare AI company that has developed a personalized physiology data analytics platform. This platform is designed to continuously collect and process data from wearable biosensors, using AI to detect subtle, clinically meaningful changes against an individual’s unique baseline rather than population-based norms. For physicians, this means an early warning system that can help transform healthcare delivery from a reactive to a proactive model, potentially identifying worsening conditions in chronic and acute care patients sooner.

The company’s technology has received FDA 510(k) clearance for its Heart Failure and Atrial Fibrillation detection analytics, as well as its platform for analyzing vital signs. This allows for continuous remote patient monitoring and provides contextualized insights into a patient’s health trajectory. PhysIQ’s platform is utilized in various settings, including clinical trials, at-home patient monitoring, and clinical care, aiming to improve outcomes for patients with conditions like heart failure, cancer, and COPD.

Focus Areas

digital medicine personalized physiology analytics AI wearable biosensor data remote patient monitoring clinical trial support digital biomarkers proactive care disease exacerbation prediction heart failure COVID-19 oncology COPD

Business Intelligence

TechnologyCloud-based platform, AI-powered algorithms, personalized dynamic baseline, device-agnostic, pinpointIQ® (patient care), accelerateIQ® (clinical trials), raw biosignal processing, deep neural networks

What Physicians Need to Know

Digital Medicine & Personalized Physiology Analytics
VGBio (DBA PhysIQ) specializes in personalized digital medicine, utilizing AI to analyze real-time physiological data from wearable sensors. They create a dynamic baseline for each individual, detecting subtle deviations that may precede disease exacerbation or changes in health.
AI & Wearable Biosensor Data
The company leverages AI and deep learning algorithms to process continuous data streams from various wearable biosensors, transforming raw data into actionable clinical insights.
Remote Patient Monitoring & Proactive Care
PhysIQ's technology enables continuous remote monitoring of patients in real-world environments, facilitating proactive care delivery models and early intervention to prevent patient deterioration.
Clinical Trial Support
They provide AI-based remote monitoring solutions for clinical trials, improving patient engagement, generating new clinical insights, and supporting virtual study designs. This helps address challenges like low participation and provides continuous, high-fidelity data.
Digital Biomarkers & Disease Exacerbation Prediction
PhysIQ develops novel, clinically-validated, FDA-approved digital biomarkers capable of predicting physiological changes from a personalized baseline, often ahead of current standards of care. This includes predicting heart failure exacerbation up to 10 days in advance.
Therapeutic Areas
Their platform and digital biomarkers are applied across various therapeutic areas, including cardiovascular (heart failure), immuno-oncology, pulmonary/respiratory (COPD, COVID-19), and sleep.
Physician Tip

Physicians can utilize VGBio (DBA PhysIQ)'s platform to gain personalized, real-time insights into their patients' physiological data, enabling earlier and more effective interventions. The predictive analytics can help anticipate disease exacerbations, particularly in conditions like heart failure, and support remote patient management. For clinical trials, the technology offers a means to gather continuous, high-fidelity data and enhance patient participation through virtual study designs. The FDA-cleared analytics and digital biomarkers provide a robust tool for proactive care and personalized medicine.

PhysIQ's platform is designed to collect and analyze data from various wearable biosensors, including customized Samsung Galaxy Watches and other Bluetooth-enabled sensors. The data is streamed to the cloud, where AI-powered algorithms provide actionable insights.

Products by VGBio (DBA PhysIQ)

No products listed for this company yet. Know of one? Suggest it →

What the Web Says

PhysIQ (DBA VGBio) appears to be primarily known for its non-invasive body contouring treatments and as a fitness center. Reviews for the body contouring product highlight its effectiveness in reducing fat and toning muscles with no downtime, making it a convenient option for many. However, reviews for the fitness centers, particularly on Reddit and BBB, frequently mention issues with billing practices, customer service, and cleanliness, leading to a mixed perception of the company. Employer reviews for Physiq Fitness also show a mixed bag, with some praising the positive environment and growth opportunities, while others criticize unfair pay and poor management.

Overall: Mixed

Strengths

  • Physiq body contouring treatments are non-invasive and require no downtime.
  • The body contouring treatments can target multiple areas for fat reduction and muscle definition.
  • Physiq body contouring allows users to control energy modulation for comfort during treatment.
  • Fitness centers are described as having good equipment and being clean by some users.
  • Some employees found Physiq Fitness to be a fun workplace with a positive environment and opportunities for growth.
  • Physiq Apparel products are praised for high-quality materials, stylish designs, and comfortable fit.

Limitations

  • Frequent complaints about unethical and dishonest billing practices at Physiq fitness centers, including double charging and difficulty with cancellations.
  • Poor customer service at fitness centers, with emails going unanswered and staff unable to resolve issues.
  • Fitness centers can be crowded, and some locations have parking issues.
  • Lack of cleanliness and maintenance in some fitness centers, including missing paper towels and soap.
  • Employer reviews mention unfair pay, inconsistent scheduling, and poor management at Physiq Fitness.
  • Physiq Apparel is criticized for higher price points, limited size range, and occasional shipping delays.

Based on reviews from: reddit.com, worthepenny.com, nashvillewifestyles.com, weighlesswellnessclinic.com, emilyfrostaesthetics.com, trustpilot.com, thedevicepulse.com, bbb.org, youtube.com, indeed.com, g2.com, us.com, trustradius.com, capterra.com

Last updated: 2026-10-27

Videos

News, demos, and interviews about VGBio (DBA PhysIQ).

Loading videos...

Videos load interactively. If none appear, search YouTube for VGBio (DBA PhysIQ) →

View all on YouTube

Press & Coverage

businesswire.com
physIQ Announces Two New Appointments to Executive Leadership Team to Advance Digital Health Market Commercialization
PhysIQ appointed John Wilson as Senior Vice President and General Manager of Life Sciences and Chris Englerth as Vice President of Marketing to accelerate its commercialization strategy and growth in the digital health market.
2022-05
thedevicepulse.com
What's the latest news and updates for PHYSIQ in 2026?
As of April 2026, PHYSIQ, a body contouring device by Cartessa Aesthetics, remains commercially available, with recent updates including financial disclosures, clinical evidence, software updates, and FDA labeling changes.
2026-09
cartessaaesthetics.com
Cartessa Aesthetics Unveils PHYSIQ 360, A Revolutionary Non-Invasive Body Contouring Treatment
Cartessa Aesthetics launched PHYSIQ 360, an upgraded body contouring system featuring enhanced Sequential Thermal and Electrical Pulsing (STEP) with PURE BEAM Technology for targeted fat reduction and muscle stimulation.
2024-05
medicalalley.org
PhysIQ Saw Significant Adoption of Their AI Technology in 2020
PhysIQ achieved significant milestones in 2020, including breakthrough studies, partnerships, and an additional FDA clearance for its AI-based digital medicine platform, particularly in continuous remote patient monitoring during the COVID-19 pandemic.
2021-01
bioxconomy.com
physIQ rolls out data streaming tech scheme for CROs
PhysIQ launched the Intrepid Partner Program, a data streaming technology scheme designed to provide Contract Research Organizations (CROs) with real-time access to patient data, aiming to enhance patient safety and clinical trial innovation.
2022-11
purdue.edu
Purdue-affiliated health technology company physIQ receives $500,000 to advance AI innovations
PhysIQ, a Purdue University-affiliated company, received a $500,000 investment from Purdue Research Foundation's Foundry Investment Fund to advance its AI-based medical technology for improving healthcare outcomes through real-time physiological data from wearable sensors.
2020-01
medicalalley.org
PhysIQ Inc. Receives FDA Clearance of Continuous Ambulatory Respiration Rate Algorithm Enabling Artificial Intelligence-based Analytics for Biopharma Companies and Payers
PhysIQ received 510(k) clearance from the FDA for its algorithm that continuously determines respiration rate in ambulatory patients, expanding its portfolio of FDA-cleared cloud-based analytics for wearable sensor data.
2019-08
biospace.com
PhysIQ announces FDA-sanctioned labeling to address the COVID-19 public health emergency with its proprietary Multivariate Change Index (MCI)
PhysIQ announced FDA-sanctioned labeling for its pinpointIQ® continuous remote monitoring system, including its Multivariate Change Index (MCI), for use in the COVID-19 pandemic to monitor homebound or quarantined patients.
2020-03

Frequently Asked Questions

PhysIQ provides an FDA-cleared, AI-powered digital platform that uses wearable biosensor data to create a personalized dynamic baseline for each individual. This platform continuously monitors multiple vital signs, detecting subtle deviations from a patient's unique baseline that may indicate disease exacerbation or a change in health, enabling proactive and personalized care.
PhysIQ's platform collects continuous physiological data from wearable biosensors and applies proprietary, FDA-cleared AI-based analytics to process this raw data. This allows for near real-time monitoring and the detection of subtle physiological changes that can predict disease exacerbations in conditions like heart failure, COVID-19, and COPD, often before symptoms are apparent.
Yes, PhysIQ offers specialized solutions like VitaLink and accelerateIQ for clinical trial support. Their device-agnostic, CFR Part 11-compliant cloud platform collects and analyzes continuous real-world data from biosensors, providing researchers with personalized insights and digital biomarkers across various therapeutic areas, including cardiovascular health, oncology, and neurocognitive disease. This helps accelerate drug development and improve patient safety and efficacy assessments.
PhysIQ's technology is applied across various disease areas, including heart failure, COVID-19, oncology, and COPD. For instance, it has been shown to predict heart failure hospitalizations up to ten days in advance and is used to monitor high-risk COVID-19 patients for early signs of deterioration. The platform also supports proactive identification and management of adverse events in oncology patients undergoing treatments.
PhysIQ has established partnerships with various organizations, including collaborations for clinical trials with entities like Science 37 and integration with platforms from companies like Samsung. The company was founded in 2011 and has been recognized for its technological advancements. Recently, PhysIQ was acquired by Prolaio to enhance its connected heart care technology, indicating a strategic move for continued growth and integration within the digital health landscape.

Related Companies

CoCounsel
Toronto, Ontario, Canada

CoCounsel, developed by Thomson Reuters, is a professional-grade generative AI assistant primarily designed for legal professionals, but its underlying AI technology is also applied across other professional domains like tax, accounting, audit, risk, compliance, and global trade. For physicians, understanding CoCounsel’s capabilities in the legal and compliance space is relevant, especially when dealing with legal […]
OrthoAI
Pune, Maharashtra, India (for the surgical companion OrthoAI), Abu Dhabi (for the dental AI OrthoAI), unknown (for the US-based OrthoAI)

OrthoAI is a healthcare AI company that has two distinct entities. One OrthoAI, based in India, is an AI-powered surgical companion designed for orthopedic surgeons, providing evidence-based insights and decision support. It functions as a generative AI, similar to ChatGPT, specifically tailored for orthopedics, and is accessible 24/7. This platform integrates a curated database developed […]
NuvoAir
Boston, MA, USA

NuvoAir is a digital health company that provides a value-based specialty care platform focused on proactive, continuous virtual care for individuals with heart and lung conditions. The company aims to transform the diagnosis and management of chronic cardiopulmonary conditions by integrating advanced monitoring technology, data analytics, and evidence-based interventions delivered by a multidisciplinary team. NuvoAir’s […]
Infinite Biomedical Technologies, LLC (IBT)
8 Market Place, Suite 500, Baltimore, MD 21202, USA

Infinite Biomedical Technologies, LLC (IBT) is a medical device company established in 1997 with roots at Johns Hopkins University. The company is dedicated to developing innovative solutions for individuals with upper limb loss and differences, aiming to transform laboratory research into practical medical devices. IBT focuses on advanced prosthetic control systems and related technologies to […]
St
Strain AI

The search results indicate that “Strain AI” is not a single, unified company serving physicians and healthcare providers in the traditional medical sense. Instead, the term “Strain AI” appears to be a general descriptor used by several distinct companies operating primarily in the cannabis industry, leveraging AI to recommend cannabis strains based on user preferences, […]
Samsung
Suwon, South Korea

Samsung is a global technology leader that has significantly expanded its presence in the healthcare sector, leveraging its expertise in AI, imaging, and connected devices. The company aims to improve patient care and outcomes by providing advanced diagnostic solutions, personalized health insights, and integrated digital health platforms. Samsung’s healthcare initiatives focus on bridging the gap […]
Suggest an Edit → | Report an issue
AI Tool Finder
AI-powered search. Results may not be comprehensive.